The findings thus far had shown that i.p. injected IL-2c preferentially bind CD122+ cells in blood and lymphoid tissue and to a much lower extent in the tumor, suggesting that tumor-specific T and NK cells expanded by IL-2c in extratumoral compartments markedly contribute to local tumor control. The gene discussed is IL2RB; the disease is neoplasm.